CHUL
2705, boulevard Laurier
T4-50
Québec, Québec
Canada G1V 4G2
2705, boulevard Laurier
T4-50
Québec, Québec
Canada G1V 4G2
Dernières nouvelles
- Chen, Xiao YuanEmployéCHUL+1 418-525-4444, poste 42296xiao-yuan.chen@crchudequebec.ulaval.ca
2705, boulevard Laurier
T4-50
Québec, QC
Canada G1V 4G2 - Lahdiri, NassimÉtudiant 3e cycleCHUL+1 418-525-4444, poste 42296nassim.lahdiri.1@ulaval.ca
2705, boulevard Laurier
T-450
Québec, QC
Canada G1V 4G2 - Roy, JennyEmployéCHUL+1 418-525-4444, poste 42296 / 48736jenny.roy@crchudequebec.ulaval.ca
2705, boulevard Laurier
T-450 / P-09330
Québec, Québec
Canada G1V 4G2 - Wang, RuixuanÉtudiant 3e cycleCHUL+1 418-525-4444, poste 42296ruixuan.wang.1@ulaval.caruixuan.wang@crchudequebec.ulaval.ca
2705, boulevard Laurier
T4-50
Québec, Québec
Canada G1V 4G2
Arginyl-tRNA synthetase from Escherichia coli affinity labeling with 3'-oxidized tRNA(Arg)
Article de revueSci China B, 34 (3), 1991.
Demonstration of a slow conformational change in liver glucokinase by fluorescence spectroscopy
Article de revueJ Biol Chem, 265 (17), 1990.
Signaler des ajouts ou des modifications
Projets actifs
- Pre-clinical pharmacokinetic and efficacy assays with an efficient 17beta-hydroxysteroid dehydrogenase type 7 inhibitor for breast cancer therapy, du 2024-03-01 au 2025-02-28
Projets terminés récemment
- 3alpha-hydroxysteroid dehydrogenase type 3 as a modulator of human adipose tissue function and distribution, du 2020-04-01 au 2024-03-31
- Innovative therapeutic approaches for the 2019-novel coronavirus, du 2021-03-01 au 2024-03-31